Research Topics
| Mark JitSummaryAffiliation: Health Protection Agency Country: UK Publications
| Collaborators
|
Detail Information
Publications
Enzymes provide demographers with food for thoughtMark Jit
is in the Modelling and Economics Unit, Health Protection Agency, London, UK, and the Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom
elife 1:e00340. 2012..Life expectancy has increased by 20 years since the middle of the last century, but children under five have fared better than adult males...
Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the worldMaarten J Postma
Unit of PharmacoEpidemiology and PharmacoEconomics PE2, Department of Pharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands
BMC Med 9:84. 2011....
Modelling the epidemiology of infectious diseases for decision analysis: a primerMark Jit
Modelling and Economics Unit, Centre for Infections, Health Protection Agency, London, UK
Pharmacoeconomics 29:371-86. 2011....
Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission modelMark Jit
Health Protection Agency, London NW9 6BT, UK
BMJ 343:d5775. 2011....
The cost-effectiveness of rotavirus vaccination in ArmeniaMark Jit
Modelling and Economics Unit, Health Protection Agency, 61 Colindale Avenue, London NW9 6BT, United Kingdom
Vaccine 29:9104-11. 2011..Vaccination may still be "very cost-effective" if less favourable assumptions are used regarding vaccine price and disease incidence, as long as DALYs are not age-weighted...
The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and WalesMark Jit
Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 6BT, United Kingdom
Vaccine 29:115-22. 2010..Key sources of uncertainty are the cost of vaccine delivery and the quality of life detriment due to a clinically apparent episode of confirmed influenza. The cost of vaccine purchase itself is relatively low...
The risk of sequelae due to pneumococcal meningitis in high-income countries: a systematic review and meta-analysisMark Jit
Modelling and Economics Unit, Health Protection Agency Centre for Infections, London, UK
J Infect 61:114-24. 2010..To determine the risk of various kinds of sequelae in survivors of meningitis due to Streptococcus pneumoniae, as well as the influence of co-factors such as study design, study population and treatment on this risk...
Estimating progression rates for human papillomavirus infection from epidemiological dataMark Jit
Modelling and Economics Unit, Health Protection Agency Centre for Infections, London, United Kingdom
Med Decis Making 30:84-98. 2010..The scenarios and parameter sets that produce the best fit to available epidemiological data provide a basis for modeling the natural history of HPV infection and disease...
Estimating the number of deaths with rotavirus as a cause in England and walesMark Jit
Modelling and Economics Unit, Immunisation Department, Health Protection Agency, London, UK
Hum Vaccin 3:23-6. 2007..The two methods gave estimates of 3.8 and 3.2 rotavirus deaths a year respectively...
Economic evaluation of human papillomavirus vaccination in the United KingdomMark Jit
Modelling and Economics Unit, Centre for Infections, Health Protection Agency, London NW9 6BT
BMJ 337:a769. 2008..To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls against human papillomavirus infection in the United Kingdom...
Prevalence of human papillomavirus antibodies in young female subjects in EnglandM Jit
Immunisation Department, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5HT, UK
Br J Cancer 97:989-91. 2007..7% (95% confidence intervals 9.0-12.3) for human papillomavirus (HPV) 6, 2.7% (1.8-3.6) for HPV 11, 11.9% (10.2-13.6) for HPV 16, 4.7% (3.5-5.8) for HPV 18, and 20.7% (18.6-22.7) for any of the four types...
Mathematical modelling long-term effects of replacing Prevnar7 with Prevnar13 on invasive pneumococcal diseases in England and WalesYoon Hong Choi
Health Protection Services Colindale, Health Protection Agency, London, United Kingdom
PLoS ONE 7:e39927. 2012....
7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement?Yoon Hong Choi
Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency, London, United Kingdom
PLoS ONE 6:e26190. 2011..However, recent surveillance data show a more rapid replacement of PCV7 IPD cases by non-PCV7 IPD cases than was seen in the US...
Health and economic impact of the seasonal influenza vaccination programme in EnglandMarc Baguelin
Health Protection Agency, United Kingdom
Vaccine 30:3459-62. 2012..The seasonal influenza vaccination programme in England targets individuals over 65 years old and in clinical risk groups...
Dedicated outreach service for hard to reach patients with tuberculosis in London: observational study and economic evaluationMark Jit
Health Protection Agency, London NW9 5EQ, UK
BMJ 343:d5376. 2011..To assess the cost effectiveness of the Find and Treat service for diagnosing and managing hard to reach individuals with active tuberculosis...
Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United KingdomYoon Hong Choi
Immunisation Department, HPA Centre for Infections, 61 Colindale Avenue, Colindale, London, United Kingdom
Vaccine 28:4091-102. 2010..The marginal benefit of vaccinating boys depends on the degree of protection achieved by vaccinating girls...
Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluationMarc Baguelin
Centre for Infections, Health Protection Agency, United Kingdom
Vaccine 28:2370-84. 2010..In countries where the epidemic is not so far advanced vaccination of children may be cost-effective. Similar, detailed, real-time modelling and economic studies could help to clarify the situation...
Potential overestimation of HPV vaccine impact due to unmasking of non-vaccine types: quantification using a multi-type mathematical modelYoon Hong Choi
Health Protection Services Colindale, Health Protection Agency, London, United Kingdom
Vaccine 30:3383-8. 2012..Misattribution of the causal HPV type for a particular abnormality may give rise to an apparent increase in disease due to non-vaccine HPV types following vaccination ("unmasking")...
What types of contacts are important for the spread of infections?: using contact survey data to explore European mixing patternsAlessia Melegaro
Modelling and Economics Unit, Health Protection Agency, Centre for Infections, London, UK
Epidemics 3:143-51. 2011..We observe similar patterns in each of the countries analysed, suggesting that there are consistent biological mechanisms at work...
Modelling borderline and mild dysplasia associated with HPV 6 and 11 infectionRuth Chapman
Immunization Department, Centre for Infections, Health Protection Agency, London, United Kingdom
Vaccine 29:2881-6. 2011..We investigate the contribution of HPV types 6/11 to abnormal smears and associated costs in England...
Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analystsMark Jit
Initiative for Vaccine Research, World Health Organization, 20 Avenue Appia, CH 1211 Geneva, Switzerland
BMC Med 11:23. 2013..This report describes the consensus of an expert group convened by the World Health Organization, prioritizing key issues to be addressed when considering economic analyses to support HPV vaccine introduction in these countries...
The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in EnglandAlbert Jan van Hoek
Immunisation, Hepatitis and Blood Safety Department, Health Protection Services, Colindale, Health Protection Agency, London NW9 5EQ, UK
Vaccine 30:7205-13. 2012....
The impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based studyAlbert Jan van Hoek
Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency, London, United Kingdom
PLoS ONE 6:e17030. 2011..Such a measure would allow comparison with other diseases and assessment of the cost-effectiveness of pandemic control measures...
Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness modelsMark Jit
Modelling and Economics Unit, Health Protection Agency, London, UK
BMC Med 9:54. 2011..To provide information about the feasibility of using such models in a developing country setting, we evaluated models of HPV vaccination in terms of their capacity, requirements, limitations and comparability...
A stochastic model to evaluate options for antenatal genetic screeningSteve Gallivan
Clinical Operational Research Unit, Department of Mathematics, University College London, Gower Street, London, UK
Health Care Manag Sci 9:111-24. 2006..The model has been implemented as a computer package that can be used to inform decisions made by health care planners...
Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccinationM Jit
Modelling and Economics Unit, Centre for Infections, Health Protection Agency, London, United Kingdom
Vaccine 25:3971-9. 2007..Two rotavirus vaccines (RotaTeq and Rotarix) have recently completed clinical trials. We investigated whether routine infant immunisation with either vaccine can be cost effective...
Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of diseaseJ P Harris
Environmental and Enteric Diseases Department, Centre for Infections, Health Protection Agency, United Kingdom
Vaccine 25:3962-70. 2007..This study provides a sound basis on which to make this assessment and serves as a baseline against which any reductions that do occur if vaccination is introduced can be measured against...
Restructuring routine elective services to reduce overall capacity requirements within a local health economyMartin Utley
Clinical Operational Research Unit, University College London, Gower Street, London WC1E 6BT, UK
Health Care Manag Sci 11:240-7. 2008..As an illustration of the analysis, we present results obtained using data concerning urological services, for which there would seem to be benefits associated with the introduction of a TC in only a limited range of circumstances...
